Your MDR clock is ticking.

We just solved it.

From 2026 every Class IIb/III device must collect continuous, structured real-world evidence. Most manufacturers still rely on paper forms that disappear in 40–60 % of cases and cost £25k–£80k per 1,000 evaluations to chase.

Medisphere AX gives you four things no other platform can:

• 100 % of your existing form digitised – Reps keep the exact layout they already know and surgeons get a digitised magic link to collate the data.

• >98 % same-day capture – magic-link, no login, no app, instant e-signature, lot scanning, image and video uploads and optional patient consent toggle.

• The only blinded benchmark pool – see exactly how your product performs against every competitor in real theatres, without ever revealing identities.

• Multi Centre Trials - Analyse larger patient pools. with MAX this becomes standard as every rep will be evaluating their product portfolios across the country.

  - Deploy your first product line in under 14 days 
  - Eliminate data entry and OCR costs permanently 
  - Generate regulatory deliverables months ahead of schedule 
  - Turn clinical feedback into actionable product intelligence in real time

Result: instant PSUR/PMCF reports, perfect audit trail, faster Notified Body sign-off, and the strongest clinical evidence you’ve ever shown to procurement or payers.

Founding Manufacturer Programme UK MedTech – limited to the first 20 partners

• Locked-in grandfather pricing

• Co-branded case studies with NHS reference sites

• Priority access to the blinded pool from day one

• Input into roadmap (multi-centre trials, implants module, US expansion)

Driving better devices, faster adoption, safer surgery and better patient care.

Secure your category leadership before the pool becomes mandatory